Sponsors (2)
The bill conditions federal funding to exclude entities that operate supervised injection sites—reinforcing alignment with federal criminal law and preserving funds for compliant entities—while risking reduced harm-reduction services, greater public-health harms, and increased burdens on states and Tribal communities.
State, local, Tribal, and private entities that do not operate supervised injection sites retain eligibility for federal grants, preserving funding for other public services.
Federal funding policy is aligned with existing federal criminal law for drug-related facilities, creating a single legal standard for funding decisions.
Localities, nonprofits, and other operators of supervised injection sites risk losing federal grants, contracts, Medicaid, and other assistance, which could reduce availability of harm-reduction and treatment services.
Tribal governments and providers on Tribal lands that operate supervised injection sites could lose federal funding, further limiting already scarce health services in Tribal communities.
The policy could push supervised injection programs underground or out of jurisdiction, reducing oversight and potentially increasing public-health risks for people who use drugs, low-income individuals, and others who rely on these services.
Based on analysis of 2 sections of legislative text.
Denies federal funds to any state, local, Tribal, or private entity that operates or controls an injection center in violation of 21 U.S.C. § 856.
Prohibits the use of federal funds for any State, local, Tribal, or private entity that operates or controls an injection center in violation of federal law (21 U.S.C. § 856). It does not change criminal penalties but conditions federal financial assistance by denying funds to entities that operate unlawful injection sites. The measure applies the existing civil, criminal, and injunctive provisions of the cited statute through a federal funding restriction, affecting governments, nonprofits, and health providers that operate or partner with supervised injection facilities or similar sites.
Introduced January 3, 2025 by Nicole Malliotakis · Last progress January 3, 2025